STAT Plus: This cancer company is biotech’s most volatile non-Covid-19 stock
MARK LENNIHAN/AP
Iovance Biotherapeutics has seen volatility all without signing a deal, presenting data, or experiencing any other usual causes for value fluctuation.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario